Effect of pravastatin on cardiovascular events in women after myocardial infarction: The Cholesterol and Recurrent Events (CARE) trial

Journal of the American College of Cardiology

Volumn 32, Issue 1, 1998, Pages 140-146

  Lewis, Sandra J ^a   Sacks, Frank M ^b,j   Mitchell, Jayne S ^a   East, Cara ^c   Glasser, Stephen ^d   Kell, Sheren ^e   Letterer, Rebecca ^f   LiMacHer, Marian ^g   Moye, Lemuel A ^h   Rouleau, Jean L ⁱ   Pfeffer, Marc A ^b   Braunwald, Eugene ^b  

^a LEGACY GOOD SAMARITAN HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

^g UNIVERSITY OF FLORIDA HEALTH JACKSONVILLE   (United States)

^h UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ MONTREAL HEART INSTITUTE   (Canada)

^j HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PRAVASTATIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY RISK; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROKE; TRANSLUMINAL CORONARY ANGIOPLASTY;

ADULT; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIPIDS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POSTMENOPAUSE; PRAVASTATIN; RECURRENCE; SURVIVAL RATE;

EID: 17144464838     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00202-2     Document Type: Article

References (37)

1. Heart and Stroke Facts 1996 Statistical Supplement . 1995;3 American Heart Association, Dallas (TX).
2. Eaker E.D., Cheseboro J.H., Sacks F.M., Wenger N.K., Whisnant M.D., Winston M. Cardiovascular disease in women American Heart Association Medical/Scientific Statement Special Writing Group . Circulation. 88:(4 Pt 1):1993;1999-2009.
3. Ayanin J.Z., Epstein A.M. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 325:1991;221-225.
4. Eaker E.D., Packard B., Wenger N.K., Clarkson T.B., Tyroler H.A. Coronary artery disease in women. Am J Cardiol. 61:1988;641-644.
5. Walsh J.M.E., Grady D. Treatment of hyperlipidemia in women. JAMA. 274:1995;1152-1158.
6. Buchwald H., Varco R.L., Matts J.P., et al. Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia report of the program on the surgical control of the hyperlipidemias (POSCH) . N Engl J Med. 323:1990;946-955.
7. Carlson L.A., Rosenhamer G. Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid. Acta Med Scand. 223:1988;405-418.
8. Five-year study by a group of physicians of the Newcastle Upon Tyne region: trial of clofibrate in the treatment of ischaemic heart disease. BMJ 1971;4:767-75.
9. Ischaemic heart disease a secondary prevention trial using clofibrate . BMJ. 4:1971;775-784.
10. Rich-Edwards J.W., Manson J.E., Hennekens C.H., Buring J.E. The primary prevention of coronary heart disease in women. N Engl J Med. 332:1995;1758-1766.
11. Buckwald H., Campos C.T., Boen J.R., et al. Gender-based mortality follow-up from the program on the surgical control of the hyperlipidemias and meta-analysis of lipid intervention trials women in POSCH and other lipid trials . Ann Surg. 224:1996;486-500.
12. Report of the National Cholesterol Education Program Expert panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Arch Intern Med 1988;148:36-69.
13. Second Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993;269:3015-22.
14. Isles C.G., Hole D.J., Hawthorne V.M., Lever A.F. Relation between coronary risk and coronary mortality in women of the Renfrew and Paisley survey comparison with men . Lancet. 339:1992;702-706.
15. Miettinen T.A., Pyorala K., Olsson A.G., et al. Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris. Circulation. 96:1997;4211-4218.
16. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 335:1996;1001-1009.
17. Sacks F.M., Pfeffer M.A., Moye L., et al. Rationale and design of a secondary prevention trial of lowering normal plasma cholesterol levels after acute myocardial infarction the Cholesterol and Recurrent Events Trial (CARE) . Am J Cardiol. 68:1991;1436-1446.
18. Snedecor G.W., Cochran W.G. Statistical Methods. 7th ed. 1980;Iowa State Univ Press, Ames (IA).
19. Kaplan E.I.L., Meier P. Nonparameteric estimation from incomplete observations. JAMA. 53:1958;457-481.
20. Gurwitz J.H., Col N.F., Avorn J. The exclusion of the elderly and women from clinical trials in acute myocardial infarction. JAMA. 268:1992;1417-1422.
21. Kannel W.B., Sorlie P., McNamara P.M. Prognosis after initial myocardial infarction the Framingham Study . Am J Cardiol. 44:1979;53-59.
22. Steingart R.M., Packer M., Hamm P., et al. Sex differences in the management of coronary artery disease. N Engl J Med. 325:1991;226-230.
23. Puletti M., Sunseri L., Curione M., Erba S.M., Borgia C. Acute myocardial infarction sex-related differences in prognosis . Am Heart J. 108:1984;63-66.
24. Becker R.C., Terrin M., Ross R., et al. Comparison of clinical outcomes for women and men after acute myocardial infarction. Ann Intern Med. 120:1994;638-643.
25. Tsuyuki R.T., Teo K.K., Ikuta R.M., Bay K.S., Greenwood P.V., Montague T.J. Mortality risk and patterns of clinical practice in 2070 patients with acute myocardial infarction, 1987-1992. Chest. 105:1994;1687-1692.
26. Greenland P., Reicher-Reiss H., Goldbourt U., Behar S. In-hospital and 1-year mortality in 1524 women after myocardial infarction. Comparison with 4315 men. Circulation. 83:1991;484-491.
27. Fisher L.D., Kennedy J.W., Davis K.B., Maynard C., et al. Association of sex, physical size and operative mortality after coronary artery bypass in the Coronary Artery Surgery Study (CASS). J Thorac Cardiovasc Surg. 84:1982;334-341.
28. Tobin J.N., Wassertheil-Smoller S., Wexler J.P., et al. Sex bias in considering coronary bypass surgery. Ann Intern Med. 107:1987;19-25.
29. Kelsey S.F., James M., Holubkov A.L., et al. Results of percutaneous transluminal coronary angioplasty in women 1985-1986; National Heart, Lung, and Blood Institutes coronary angioplasty registry. Circulation. 87:1993;720-727.
30. Kahn S.S., Nessim S., Gray R., Czer L.S., Chaux A., Matloff J. Increased mortality of women in coronary artery bypass surgery evidence for referral bias . Ann Intern Med. 112:1990;561-567.
31. Laskey W.K. Gender differences in the management of coronary artery disease bias or good clinical judgment? Ann Intern Med. 116:1992;869-871.
32. Maynard C., Litwin P.E., Martin J.S., Weaver W.D. Gender differences in the treatment and outcome of acute myocardial infarction. Arch Intern Med. 152:1992;972-976.
33. Barrett-Connor E. Sex differences in coronary heart disease. Why are women so superior? The 1995 Ancel Keys Lecture. Circulation. 95:1997;252-264.
34. Farb A., Burke A.P., Tang A.L., et al. Coronary plaque erosion without rupture into a lipid core a frequent cause of coronary thrombosis in sudden coronary death . Circulation. 93:1996;1354-1363.
35. Burke A.P., Farb A., Malcolm G.T., Liang Y.-H., Smielek J., Virmani R. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med. 336:1997;1276-1282.
36. Davies M.J. The composition of coronary-artery plaques. N Engl J Med. 336:1997;1312-1314.
37. Design features and baseline characteristics of the LIPID (Long-Term Intervention with Pravastatin in Ischemic Disease) study a randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris . Am J Cardiol. 76:1995;474-479.